The Godzilla Blend combines CJC-1295 No DAC and Ipamorelin — two growth hormone secretagogues studied for their complementary mechanisms of action on the GH axis. Each compound operates through independent receptor pathways, making this combination a subject of significant investigation in preclinical GH release research.
Compound Profiles
CJC-1295 No DAC (Modified GRF 1-29) — GHRH Analogue: A 29-amino acid analogue of growth hormone-releasing hormone. Studied for stimulation of endogenous GH release via the GHRH receptor on somatotroph cells. Produces pulsatile GH release patterns more consistent with physiological secretion. Preclinical models report increased GH and IGF-1 levels post-administration.
Ipamorelin — Selective GHS-R Agonist: A pentapeptide ghrelin mimetic studied for selective stimulation of GH release without significant elevation of cortisol, prolactin, or ACTH. Preclinical research demonstrates dose-dependent GH release with a favourable selectivity profile.
Combined Mechanism: CJC-1295 No DAC and Ipamorelin act on distinct receptor populations (GHRH-R and GHS-R respectively), producing synergistic GH release in co-administration studies.
Contents
| Component | Size | Purity |
|---|---|---|
| CJC-1295 No DAC | 5mg | 99%+ HPLC |
| Ipamorelin | 5mg | 99%+ HPLC |
Lyophilised blend, HPLC verified. Certificate of Analysis available on request.
Reconstitution Guidelines
Reconstitute with bacteriostatic water. Recommended: 1-2mg/ml per peptide equivalent.
Use our Peptide Reconstitution Calculator
Storage
Lyophilised: 2-8°C, protected from light | Reconstituted: 2-8°C, use within 28 days | Long-term: -20°C
Reviews
There are no reviews yet.